Lentiviral vectors were employed to generate shRNA targeting TGF-β1 mRNA in hOM-MSCs, while AAV was used to produce AAV ALK targeting the microglial cell surface receptor, ALK, in a PD mouse model. This evidence concerns the gene ALK and Parkinson disease.